DOI:
10.1055/s-00046370
Global Medical Genetics
LinksClose Window
References
Vincent JL, Francois B, Zabolotskikh I. et al; SCARLET Trial Group.
Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: The SCARLET randomized clinical trial.
JAMA 2019;
321 (20) 1993-2002
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.